PropertyValue
?:abstract
  • During disease outbreaks, the pharmaceutical industry generally puts a lot of effort into promoting clinical trials studying their new drugs. We review evidence of the ten most recent reports on remdesivir. We conclude that it is far too premature to identify remdesivir as a curative or life-saving intervention during the COVID-19 pandemic.
?:creator
?:doi
  • 10.1016/j.nmni.2020.100745
?:doi
?:journal
  • New_Microbes_New_Infect
?:license
  • cc-by-nc-nd
?:pdf_json_files
  • document_parses/pdf_json/3a4da80b36b03d737aa988926385617d4d29e7d3.json; document_parses/pdf_json/17c4e01affa3076cd8d4e74673ead8820c53c495.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7567956.xml.json
?:pmcid
?:pmid
?:pmid
  • 33088576.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Critical reappraisal of remdesivir investigational trials in COVID-19
?:type
?:year
  • 2020-09-28

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/j6gw6gil>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/j6gw6gil>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all